BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 27288972)

  • 1. Efficacy and safety of the Lotus Valve System for treatment of patients with severe aortic valve stenosis and intermediate surgical risk: Results from the Nordic Lotus-TAVR registry.
    De Backer O; Götberg M; Ihlberg L; Packer E; Savontaus M; Nielsen NE; Jørgensen TH; Nykänen A; Baranowski J; Niemelä M; Eskola M; Bjursten H; Søndergaard L
    Int J Cardiol; 2016 Sep; 219():92-7. PubMed ID: 27288972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study.
    Montone RA; Testa L; Fraccaro C; Montorfano M; Castriota F; Nerla R; Angelillis M; Tusa M; Giannini F; Garatti A; Tarantini G; Petronio AS; Brambilla N; Bedogni F
    Catheter Cardiovasc Interv; 2017 Dec; 90(7):1206-1211. PubMed ID: 28145039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a Repositionable and Fully Retrievable Aortic Valve in Routine Clinical Practice: The RESPOND Study and RESPOND Extension Cohort.
    Van Mieghem NM; Wöhrle J; Hildick-Smith D; Bleiziffer S; Blackman DJ; Abdel-Wahab M; Gerckens U; Linke A; Ince H; Wenaweser P; Allocco DJ; Meredith IT; Falk V
    JACC Cardiovasc Interv; 2019 Jan; 12(1):38-49. PubMed ID: 30621976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience.
    Giannini F; Latib A; Montorfano M; Ruparelia N; Romano V; Longoni M; Ferri L; Jabbour R; Mangieri A; Regazzoli D; Ancona M; Buzzatti N; Azzalini L; Tanaka A; Agricola E; Chieffo A; Alfieri O; Colombo A
    Catheter Cardiovasc Interv; 2018 Apr; 91(5):966-974. PubMed ID: 28941127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results of the REPRISE II Study.
    Meredith IT; Walters DL; Dumonteil N; Worthley SG; Tchétché D; Manoharan G; Blackman DJ; Rioufol G; Hildick-Smith D; Whitbourn RJ; Lefèvre T; Lange R; Müller R; Redwood S; Feldman TE; Allocco DJ; Dawkins KD
    JACC Cardiovasc Interv; 2016 Feb; 9(4):376-384. PubMed ID: 26892084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial Single-Center Experience With the Fully Repositionable Transfemoral Lotus Aortic Valve System.
    Jarr KU; Leuschner F; Meder B; Katus HA; Bekeredjian R; Chorianopoulos E
    J Invasive Cardiol; 2017 Jan; 29(1):30-35. PubMed ID: 27845874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II study.
    Meredith Am IT; Walters DL; Dumonteil N; Worthley SG; Tchétché D; Manoharan G; Blackman DJ; Rioufol G; Hildick-Smith D; Whitbourn RJ; Lefèvre T; Lange R; Müller R; Redwood S; Allocco DJ; Dawkins KD
    J Am Coll Cardiol; 2014 Sep; 64(13):1339-48. PubMed ID: 25257635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome With the Repositionable and Retrievable Boston Scientific Lotus Valve Compared With the Balloon-Expandable Edwards Sapien 3 Valve in Patients Undergoing Transfemoral Aortic Valve Replacement.
    Seeger J; Gonska B; Rottbauer W; Wöhrle J
    Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28566290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low permanent pacemaker rates following Lotus device implantation for transcatheter aortic valve replacement due to modified implantation protocol.
    Krackhardt F; Kherad B; Krisper M; Pieske B; Laule M; Tschöpe C
    Cardiol J; 2017; 24(3):250-258. PubMed ID: 28248410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of valve repositioning during transcatheter aortic valve replacement with the Lotus Valve System.
    Rashid HNZ; Gooley R; McCormick L; Zaman S; Ramkumar S; Jackson D; Amiruddin A; Nasis A; Cameron J; Meredith IT
    J Cardiol; 2017 Jul; 70(1):55-61. PubMed ID: 27890512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis.
    Jatene T; Castro-Filho A; Meneguz-Moreno RA; Siqueira DA; Abizaid AAC; Ramos AIO; Arrais M; Le Bihan DCS; Barretto RBM; Moreira AC; Sousa AGMR; Eduardo Sousa J
    Catheter Cardiovasc Interv; 2017 Jul; 90(1):139-146. PubMed ID: 28029207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial.
    Lanz J; Kim WK; Walther T; Burgdorf C; Möllmann H; Linke A; Redwood S; Thilo C; Hilker M; Joner M; Thiele H; Conzelmann L; Conradi L; Kerber S; Schymik G; Prendergast B; Husser O; Stortecky S; Heg D; Jüni P; Windecker S; Pilgrim T;
    Lancet; 2019 Nov; 394(10209):1619-1628. PubMed ID: 31570258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfemoral aortic valve implantation with new-generation devices: the repositionable Lotus vs. the balloon-expandable Edwards Sapien 3 valve.
    Nai Fovino L; Badawy MRA; Fraccaro C; D'Onofrio A; Purita PAM; Frigo AC; Tellaroli P; Mauro A; Tusa M; Napodano M; Gerosa G; Iliceto S; Bedogni F; AbdelRheim AER; Tarantini G
    J Cardiovasc Med (Hagerstown); 2018 Nov; 19(11):655-663. PubMed ID: 30299408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The JUPITER registry: 1-year results of transapical aortic valve implantation using a second-generation transcatheter heart valve in patients with aortic stenosis.
    Silaschi M; Treede H; Rastan AJ; Baumbach H; Beyersdorf F; Kappert U; Eichinger W; Rüter F; de Kroon TL; Lange R; Ensminger S; Wendler O
    Eur J Cardiothorac Surg; 2016 Nov; 50(5):874-881. PubMed ID: 27242354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery.
    Popma JJ; Adams DH; Reardon MJ; Yakubov SJ; Kleiman NS; Heimansohn D; Hermiller J; Hughes GC; Harrison JK; Coselli J; Diez J; Kafi A; Schreiber T; Gleason TG; Conte J; Buchbinder M; Deeb GM; Carabello B; Serruys PW; Chenoweth S; Oh JK;
    J Am Coll Cardiol; 2014 May; 63(19):1972-81. PubMed ID: 24657695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter Aortic Valve-in-Valve Implantation Using Lotus Valve for Failed Surgical Bioprostheses.
    Castriota F; Nerla R; Micari A; Cavazza C; Bedogni F; Testa L; Montorfano M; Del Giglio M; Cremonesi A
    Ann Thorac Surg; 2017 Aug; 104(2):638-644. PubMed ID: 28223056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcatheter aortic valve implantation in severe calcified annulus using the Lotus valve system: Increased incidence of fatal major vascular complications.
    Conzelmann LO; Würth A; Balthasar V; Neuber C; Tzamalis P; Gonska BD; Schmitt C; Mehlhorn U; Schymik G
    Catheter Cardiovasc Interv; 2020 Jan; 95(1):E21-E29. PubMed ID: 31115146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantation and 30-Day Follow-Up on All 4 Valve Sizes Within the Portico Transcatheter Aortic Bioprosthetic Family.
    Möllmann H; Linke A; Holzhey DM; Walther T; Manoharan G; Schäfer U; Heinz-Kuck K; Van Boven AJ; Redwood SR; Kovac J; Butter C; Søndergaard L; Lauten A; Schymik G; Worthley SG
    JACC Cardiovasc Interv; 2017 Aug; 10(15):1538-1547. PubMed ID: 28797431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of aorto-ventricular angulation on procedural success in transcatheter aortic valve replacements with the Lotus Valve system.
    Rashid HN; McCormick LM; Talman AH; Ihdayhid AR; Nerlekar N; Amiruddin AS; Cameron J; Nasis A; Meredith IT; Gooley RP
    Catheter Cardiovasc Interv; 2018 Jun; 91(7):1365-1370. PubMed ID: 29210168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfemoral Transcatheter Aortic Valve-in-Valve Implantation for Aortic Valve Bioprosthesis Failure With the Fully Repositionable and Retrievable Lotus Valve: A Single-Center Experience.
    Ruparelia N; Thomas K; Newton JD; Grebenik K; Keiralla A; Krasopoulos G; Sayeed R; Banning AP; Kharbanda RK
    J Invasive Cardiol; 2017 Sep; 29(9):315-319. PubMed ID: 28706126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.